Over the past 12 months, 4 insiders at Aldeyra Therapeutics, Inc. filed 5 open-market SEC Form 4 transactions on ALDX: 4 purchases worth $537K and 1 sale worth $114K. Insiders have been net buyers over this period. The most recent filing was on Jun 3, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 26 | Todd C BradyPresident and CEO | BUY | 250.0K | $1.67 | $418K |
| Mar 19, 26 | Richard DouglasDirector | BUY | 70.0K | $1.40 | $98K |
| Mar 18, 26 | Michael AlfieriPrincipal Financial Officer | BUY | 5.0K | $1.42 | $7K |
| Aug 13, 25 | Michael AlfieriPrincipal Financial Officer | BUY | 2.5K | $5.30 | $13K |
| Aug 11, 25 | Stephen MachathaChief Development Officer | SELL | 22.1K | $5.15 | $114K |
| Apr 3, 25 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | SELL | 3.40M | $1.42 | $4.8M |
| Aug 12, 24 | Bruce GreenbergSee Remarks | SELL | 10.8K | $4.74 | $51K |
| Aug 12, 24 | Stephen MachathaChief Development Officer | SELL | 16.0K | $4.74 | $76K |
| Apr 5, 24 | Joseph EdelmanTenPercentOwner | BUY | 37.7K | $4.74 | $179K |
| Apr 4, 24 | Joseph EdelmanTenPercentOwner | BUY | 140.3K | $4.67 | $655K |
| Apr 3, 24 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 309.8K | $4.09 | $1.3M |
| Apr 2, 24 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 186.1K | $3.44 | $640K |
| Apr 1, 24 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 8.4K | $3.25 | $27K |
| Mar 12, 24 | Stephen MachathaChief Development Officer | SELL | 11.5K | $3.16 | $36K |
| Mar 12, 24 | Todd C BradyPresident and CEO | SELL | 85.3K | $3.05 | $260K |
| Mar 11, 24 | Bruce GreenbergSee Remarks | SELL | 13.2K | $3.41 | $45K |
| Mar 11, 24 | Todd C BradyPresident and CEO | SELL | 97.9K | $3.27 | $320K |
| Mar 11, 24 | Stephen MachathaChief Development Officer | SELL | 18.2K | $3.41 | $62K |
| Oct 18, 23 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | SELL | 306.5K | $1.74 | $533K |
| Oct 16, 23 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | SELL | 2.45M | $1.60 | $3.9M |
| Apr 12, 23 | Nancy Miller-richDirector | BUY | 509 | $10.13 | $5K |
| Aug 10, 22 | Perceptive Advisors LlcTenPercentOwner | BUY | 15.0K | $7.85 | $118K |
| Aug 9, 22 | Perceptive Advisors LlcTenPercentOwner | BUY | 100.0K | $7.50 | $750K |
| Aug 8, 22 | Joseph EdelmanTenPercentOwner | BUY | 97.0K | $7.24 | $702K |
| Aug 5, 22 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 141.0K | $6.95 | $980K |
| Aug 4, 22 | Joseph EdelmanTenPercentOwner | BUY | 95.1K | $6.17 | $587K |
| Aug 3, 22 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 100.0K | $5.84 | $584K |
| Aug 2, 22 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 412.4K | $5.59 | $2.3M |
| Aug 1, 22 | Perceptive Advisors LlcTenPercentOwner | BUY | 144.2K | $5.05 | $728K |
| Jul 29, 22 | Perceptive Advisors LlcTenPercentOwner | BUY | 222.1K | $5.03 | $1.1M |
| Jul 28, 22 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 119.4K | $5.00 | $597K |
| Jun 23, 22 | Todd C BradyPresident and CEO | BUY | 17.7K | $3.36 | $59K |
| Jun 23, 22 | Martin Joseph JoyceDirector | BUY | 4.3K | $3.48 | $15K |
Over the past 12 months, insiders at Aldeyra Therapeutics, Inc. filed 4 open-market purchases worth $537K and 1 sale worth $114K on ALDX, which makes them net buyers over the period. The most recent Form 4 was filed on Jun 3, 26.
The largest recent open-market ALDX insider purchase in our data was $2.3M by Perceptive Life Sciences Master Fund Ltd, TenPercentOwner, filed on Aug 2, 22.
4 different insiders at Aldeyra Therapeutics, Inc. filed open-market SEC Form 4 transactions on ALDX over the last 12 months.
InsiderTape plots every ALDX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Aldeyra Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →